Background immunity: How important is it for SARS-CoV-2?

Silva Júnior, José Valter Joaquim; Lopes, Thaísa Regina Rocha; Weiblen, Rudi; Flores, Eduardo Furtado

Silva Júnior, José Valter Joaquim; Lopes, Thaísa Regina Rocha; Weiblen, Rudi; Flores, Eduardo Furtado.

Silva Júnior JVJ; Virology Sector, Laboratory of Immunopathology Keizo Asami, Federal University of Pernambuco, Pernambuco, Brazil.
Lopes TRR; Department of Microbiology and Parasitology, Federal University of Santa Maria, Santa Maria, Brazil.
Weiblen R; Virology Sector, Department of Preventive Veterinary Medicine, Federal University of Santa Maria, Santa Maria, Brazil.
Flores EF; Virology Sector, Laboratory of Immunopathology Keizo Asami, Federal University of Pernambuco, Pernambuco, Brazil.

J Med Virol ; 93(3): 1253-1254, 2021 03.

Article in English | MEDLINE | ID: covidwho-1384231

Subject(s)

COVID-19/immunology; COVID-19/prevention & control; Cross Protection; Immunity, Innate; Social Determinants of Health; Antibodies, Viral; BCG Vaccine/immunology; Host Microbial Interactions; Humans; Hygiene Hypothesis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cross Protection / Social Determinants of Health / COVID-19 / Immunity, Innate Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: JMV.26602

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google